$1.14
0.04[3.64%]
At close: Apr 26
$1.14
0[0.00%]
After Hours: 4:42PM EDT
Rigel Pharmaceuticals
(NASDAQ:RIGL)Latest News for Rigel Pharmaceuticals Stock (NASDAQ:RIGL)
Rigel Pharmaceuticals Stock (NASDAQ: RIGL)
Categories: All
Monday, April 22, 2024
Thursday, April 04, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
- Cantor Fitzgerald Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $3Benzinga Newsdesk - Mar 6, 2024, 12:34PM
- HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price TargetBenzinga Newsdesk - Mar 6, 2024, 8:55AM
- B. Riley Securities Maintains Neutral on Rigel Pharmaceuticals, Maintains $1.25 Price TargetBenzinga Newsdesk - Mar 6, 2024, 8:37AM
Tuesday, March 05, 2024
Monday, March 04, 2024
Friday, February 23, 2024
Thursday, February 22, 2024
- HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price TargetBenzinga Newsdesk - Feb 22, 2024, 12:27PM
- Rigel Pharmaceuticals Acquires U.S. Rights To GAVRETO From Blueprint Medicines; Blueprint Receives $15M Purchase Price; Eligible For Up To $97.5M In Commercial Milestone Payments And $5M In Future Regulatory Milestone PaymentsBenzinga Newsdesk - Feb 22, 2024, 7:53AM
Monday, January 08, 2024
Thursday, January 04, 2024
- HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price TargetBenzinga Newsdesk - Jan 4, 2024, 10:27AM
- Rigel Announces CONNECT Collaboration To Conduct Phase 2 Trial Of Olutasidenib In Glioma; CONNECT Will Include Olutasidenib In Its TarGeT-D; Rigel Provide Up To $3M In Funding And Study Material Over Four-Year CollaborationBenzinga Newsdesk - Jan 4, 2024, 8:11AM
Friday, December 08, 2023
- HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price TargetBenzinga Newsdesk - Dec 8, 2023, 9:44AM
- Rigel Pharmaceuticals Announced A Multi-year Strategic Development Collaboration To Expand The Evaluation Of Rezlidhia (Olutasidenib) In Acute Myeloid Leukemia And Other Hematologic Cancers, Rigel To Provide $15M In Time-Based Milestone PaymentsBenzinga Newsdesk - Dec 8, 2023, 8:06AM
Tuesday, November 07, 2023
Monday, November 06, 2023
Wednesday, October 18, 2023
Wednesday, August 02, 2023
Tuesday, August 01, 2023
Wednesday, June 07, 2023
Thursday, June 01, 2023
Thursday, May 18, 2023
Wednesday, May 17, 2023
Wednesday, May 03, 2023
Tuesday, May 02, 2023
Monday, May 01, 2023
Monday, April 03, 2023
Friday, March 10, 2023
Thursday, March 09, 2023
Wednesday, March 08, 2023
- Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Mar 8, 2023, 1:28PM
- Why Rigel Pharmaceuticals Stock Is Rocketing Higher TodayAdam Eckert - Mar 8, 2023, 8:50AM
- Rigel Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.Benzinga Newsdesk - Mar 8, 2023, 8:50AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Mar 8, 2023, 8:06AM
- Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving PremarketLisa Levin - Mar 8, 2023, 7:57AM
- HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price TargetBenzinga Newsdesk - Mar 8, 2023, 6:06AM
Tuesday, March 07, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Mar 7, 2023, 4:31PM
- Rigel Pharmaceuticals Q4 EPS $0.01 Beats $(0.11) Estimate, Sales $51.30M Beat $27.97M EstimateBenzinga Newsdesk - Mar 7, 2023, 4:03PM
- Earnings Scheduled For March 7, 2023Benzinga Insights - Mar 7, 2023, 4:37AM